Our partners at HalioDx SAS, an immuno-oncology diagnostic company headquartered in Marseille, France, recently announced that their diagnostic test Immunoscore® has been included in the 2020 European Society of Medical Oncology (ESMO) Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up for Localised Colon Cancer. Immunoscore® was considered for its ability to refine the prognosis for [...]
Congratulations to the team of Barbara Lupo, Francesco Sassi, Marika Pinnelli, Francesco Galimi, Eugenia R. Zanella, Valentina Vurchio, Giorgia Migliardi, Paolo Armando Gagliardi, Alberto Puliafito, Daria Manganaro, Paolo Luraghi, Michael Kragh, Mikkel W. Pedersen, Ivan D. Horak, Carla Boccaccio, Enzo Medico, Luca Primo, Daniel Nichol, Inmaculada Spiteri, Timon Heide, Alexandra Vatsiou, Trevor A. Graham, Elena Élez, Guillem Argiles, Paolo Nuciforo, Andrea Sottoriva, Rodrigo Dienstmann, Diego Pasini, Elena Grassi, Claudio Isella, Andrea Bertotti and Livio Trusolino for their recent publication in Science Translational Medicine. The paper [...]
Cancer Trials Ireland was established in 1996 under the name of Irish Cooperative Oncology Research Group (ICORG). A group of cancer consultants had the aim to create more opportunities for patients to access cutting edge treatments by putting a formal structure in place, which could make Ireland more attractive as a location to international cancer [...]
Hear ye! Hear ye! The Spring 2020 COLOSSUS newsletter is out now! Read the latest update on the COLOSSUS translational study from partners at Cancer Trials Ireland, a spotlight feature on our partner HalioDx, the dissemination round-up and much more!
VHIO hosts interactive public meeting drawing together stakeholders in colorectal cancer treatment and care
Principal Investigators (PIs) involved in the COLOSSUS and MoTriColor projects hosted a packed public meeting for people with colorectal cancer, their carers, and relatives on February 27, 2020, at the Vall d´Hebron Institute of Oncology in Barcelona. Berta Colldeforns Riera of VHIO, one of the co-organizers of this interactive event reported: "Everyone seemed very interested [...]
VIB hosts Tumor Heterogeneity, Plasticity and Therapy meeting, 14-15 May 2020- travel grants are available
Our partners VIB, a non-profit life sciences research institute in Belgium, is pleased to announce the first Tumor Heterogeneity, Plasticity and Therapy meeting which will be held on May 14-15, 2020 in the historical city of Leuven, Belgium. The upcoming deadlines are: Travel Grant application deadline: 27 February 2020 Abstract deadline: 12 March 2020 When you submit your abstract for [...]
COLOSSUS teams up with MoTriColor for February 27th event “Advances and new horizons in the diagnosis and treatment of colorectal cancer”
In advance of the launch of Colorectal Cancer Awareness Month (March) 2020, COLOSSUS partners at VHIO have organized a special public event on Thursday, the 27th of February, from 18:00h-20:00h, at C/Rosselló, 231, 2-1 in Barcelona. Download the promotional flyer in PDF here: What is changing in the diagnosis and treatment of CRC_ (003) As [...]
Congratulations to authors Wolf H.Fridman, Ian Miller, CatherineSautès-Fridman, and Annette T.Byrne for their most recent paper published in Volume 158, Issue 2 edition of Gastroenterology dated January 2020, (pages 303-321). The open-access review is entitled: Therapeutic Targeting of the Colorectal Tumor Stroma.
COLOSSUS featured in the Cancer Trials Ireland publication, Winter 2019 DSSG Digest. You can download the full report here: http://bit.ly/2OvqN7G
Congratulations to all researchers involved in two COLOSSUS-acknowledged publications! The first, Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga, appears in the December 2019 edition of Trends in Cancer. The piece was authored by the team of Irene Catalano, Elena Grassi, Andrea Bertotti, and Livio Trusolino of the Universita degli Studi di [...]